5-Amino-1MQ Peptides For Bodybuilding CAS:42464-96-0
5-Amino-1MQ (5-Amino-1-methylquinolinium) is a novel small molecule compound, often mistakenly categorized as a peptide due to its niche in metabolic research. Developed to target nicotinamide N-methyltransferase (NNMT), an enzyme linked to metabolic regulation, it emerged from studies exploring obesity and metabolic syndrome.
Introduction to 5-Amino-1MQ
5-Amino-1MQ (5-Amino-1-methylquinolinium) is a novel small molecule compound, often mistakenly categorized as a peptide due to its niche in metabolic research. Developed to target nicotinamide N-methyltransferase (NNMT), an enzyme linked to metabolic regulation, it emerged from studies exploring obesity and metabolic syndrome. Unlike traditional peptides or SARMs, 5-Amino-1MQ operates through epigenetic modulation, offering a unique approach to body composition optimization.
Mechanism of Action
5-Amino-1MQ inhibits NNMT, which typically methylates nicotinamide (a form of vitamin B3), reducing its availability for NAD+ synthesis. By blocking NNMT, cellular nicotinamide levels rise, enhancing NAD+ production. Elevated NAD+ activates sirtuins, proteins critical for mitochondrial biogenesis and energy metabolism. This cascade enhances lipid oxidation, spares muscle glycogen, and promotes muscle endurance, making it valuable for bodybuilders during cutting phases.
Key Features
●Chemical Structure: A quinoline derivative with a methyl group and amino substitution, ensuring stability and oral bioavailability.
●Administration: Typically oral, with studies suggesting sublingual or enteric-coated formulations to bypass first-pass metabolism.
●Selectivity: Targets NNMT without affecting other methyltransferases, minimizing off-target effects.
Applications in Bodybuilding
●Fat Loss: Enhances lipolysis via upregulated NAD+-dependent pathways, particularly in visceral fat.
●Muscle Preservation: Activates AMPK, promoting energy efficiency and reducing catabolism during caloric deficits.
●Endurance Boost: Improved mitochondrial efficiency supports prolonged high-intensity training.
●Recovery Acceleration: Reduces oxidative stress and inflammation post-exercise through sirtuin activation.
Benefits
●Targeted Fat Reduction: Unlike stimulants, it specifically mobilizes stubborn adipose tissue without muscle wasting.
●Anti-Aging Effects: Increased NAD+ may improve skin elasticity and cognitive function, ancillary benefits for athletes.
●Metabolic Flexibility: Enhances switch between glycolytic and oxidative metabolism, crucial for varied training regimens.
Dosage and Administration
●Animal Studies: Mice received 50 mg/kg, translating via body surface area to ~4 mg/kg in humans (280 mg for 70 kg individual).
●Anecdotal Reports: Users start with 50 mg/day, escalating to 100-150 mg divided into two doses to align with the 6-8 hour half-life.
●Cycling: 8-12 week cycles followed by 4-week breaks to prevent potential NNMT rebound or methylation pathway adaptation.
Half-Life and Timing
With a half-life of ~7 hours, twice-daily dosing maintains stable levels. Morning and pre-workout administration optimize fat oxidation during training.
Post-Cycle Therapy (PCT)
As 5-Amino-1MQ doesn't suppress HPA axis or sex hormones, traditional PCT (e.g., SERMs) isn't required. However, supporting methylation with folate or B12 supplements may mitigate long-term NNMT inhibition effects.
Safety and Side Effects
●Short-Term: Mild gastrointestinal discomfort reported.
●Long-Term Risks: Theoretical concerns about altered methylation patterns affecting neurotransmitter synthesis; monitoring homocysteine levels advised.
Comparative Analysis
●vs. Clenbuterol: Non-stimulant, avoiding tachycardia or shakes.
●vs. NAD+ Precursors (NMN/NR): Directly boosts NAD+ via enzyme inhibition rather than substrate supplementation, offering potent effects.
Legal Status
Currently a research chemical, not approved for human consumption. Sourced through specialized labs for "experimental use," necessitating third-party purity verification.
Future Directions
Ongoing trials explore synergies with ketogenic diets and senolytics. Patent filings suggest interest in combinatory therapies for age-related muscle loss (sarcopenia).
User Guidelines
●Sourcing: Opt for vendors providing COAs (Certificates of Analysis) for purity.
●Storage: Stable at room temperature; avoid humidity to prevent degradation.
●Stacking: Pair with omega-3s to enhance lipid oxidation or berberine for glucose metabolism synergy.
Clinical Data
|
Trade names |
5-amino-1-methylquinolinium,SCHEMBL6403148,CHEMBL4116828, ZMJBCEIHNOWCMC-UHFFFAOYSA-O,STL196667 |
|
CAS |
42464-96-0 |
|
Molar mass |
159.21 |
|
Formula |
C10H11N2 |
|
Purity |
Above 98% |
|
Apprarance |
5mg/vial, 10vials/box |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885
Conclusion
5-Amino-1MQ represents a paradigm shift in metabolic manipulation for bodybuilding, merging fat loss with muscle preservation through epigenetic mechanisms. While promising, its experimental status warrants cautious use, emphasizing dosage precision and health monitoring.
Hot Tags: 5-amino-1mq peptides for bodybuilding cas:42464-96-0, China 5-amino-1mq peptides for bodybuilding cas:42464-96-0 manufacturers, suppliers, factory
